Trey Martin is the CEO of Maravai LifeSciences, bringing over 26 years of experience in the life sciences industry. Known for his focus on vision, culture, and growth, Martin has held significant roles at companies like Danaher Corporation and Integrated DNA Technologies. His leadership is expected to drive Maravai's strategic growth and innovation in the field.
Who is the CEO of Maravai LifeSciences?
With a career spanning over 25 years in the life sciences industry, Trey Martin has held pivotal roles that have shaped his expertise in operations, engineering, sales, product development, and marketing. Before becoming the CEO of Maravai LifeSciences in July 2023, Martin served as President of Biologics Safety Testing at Maravai and held senior leadership positions at Danaher Corporation, including Senior Vice President of Genomic Medicines and President of Integrated DNA Technologies (IDT).
His extensive experience and strategic vision are expected to drive Maravai's growth and innovation in the field.
Work History
Trey Martin's work history includes a series of significant roles at various esteemed organizations. Here is a detailed list of his previous positions:
- Danaher Corporation - Senior Vice President of Genomic Medicines (2018 to 2023)
- Integrated DNA Technologies (IDT) - President (2015 to 2018)
- Maravai LifeSciences - President of Biologics Safety Testing (2020 to 2023)
Education History
Trey Martin's educational background is as impressive as his professional journey. He holds a Bachelor of Science degree in Biochemistry from the University of Iowa, where he developed a strong foundation in the life sciences. This academic grounding has been instrumental in his ability to navigate and lead within the complex landscape of the biotechnology and life sciences industries. His education has provided him with the technical knowledge and analytical skills necessary to drive innovation and growth in his various leadership roles.
When did Trey Martin join Maravai LifeSciences?
Joining Maravai LifeSciences in December 2022, Trey Martin initially served as President of Biologics Safety Testing. He became the CEO in July 2023, bringing with him over 25 years of experience in the life sciences industry. Martin's tenure at Maravai LifeSciences has been marked by his strategic vision and leadership, which are expected to drive the company's growth and innovation. With a Bachelor of Science degree in Biochemistry from the University of Iowa, Martin's educational background has been instrumental in his ability to navigate the complex landscape of biotechnology and life sciences. As of now, he has been with Maravai LifeSciences for nearly a year, contributing significantly to its mission and strategic direction.